Research Areas
In ths section, by far, most Axon Ligands™ are categorized as research tools that find their application in cell signaling and oncology. Targeting a multitude of specific enzymes and receptors, they either stimulate or block particular cellular signaling pathways that are implicated in various kinds of cancer. Naturally, all products in this section can also be found by their specific biological targets as listed in the sections of enzymes, receptors, transcription factors, proteins and/or signaling pathways. Besides the comprehensive set of compounds that targe cell signaling and oncology, selections of Axon Ligands™ have also been made for other research area's such as cardiovascular diseases, angiogenisis, epigenetics, stem cell research, among many others.
| Axon ID | Name | Description | From price | |
|---|---|---|---|---|
| 3039 | ACY-241 | Selective and orally available HDAC6 inhibitor | €120.00 | |
| 2269 | AK 1 | Potent inhibitor of SIRT with good selectivity for SIRT2 over SIRT1 and SIRT3 | €90.00 | |
| 2270 | AK 7 | Potent, brain-permeable and selective inhibitor of SIRT2 | €90.00 | |
| 1490 | Anacardic acid A | HAT inhibitor | €60.00 | |
| 2394 | AR-42 | HDAC inhibitor | €125.00 | |
| 5052 | Axon Ligands™ Epigenetic compound library | Axon Ligands™ Epigenetic compound library | Inquire | |
| 2635 | BAY-598 | Selective inhibitor of SMYD2 | €110.00 | |
| 2735 | BCI-121 | Inhibitor of SMYD3 | €90.00 | |
| 3115 | Belinostat | HDAC inhibitor | €70.00 | |
| 3037 | BET BRD4 inhibitor compound II-25 | Potent, selective and orally active BET inhibitor | €165.00 | |
| 1692 | BIX 01294 trihydrochloride | HMTase inhibitor (G9a and G9a-like protein) | €80.00 | |
| 2306 | Bizine | Potent LSD1 inhibitor with selectivity over MAO-A/B, and LSD2 | €120.00 | |
| 2471 | BRD 73954 | Dual HDAC 6/8 inhibitor with excellent selectivity over the other HDACs | €85.00 | |
| 1781 | C 646 | HAT inhibitor (p300/CBP selective) | €60.00 | |
| 2803 | Cambinol | Inhibitor of SIRT1 and SIRT2 | €95.00 | |